Recent DSGN Stock Price | DSGN Stock Predictions | |
$3.65 | +27.95% |
$4.67 |
Recent DSGN Analyst Ratings Breakdown, Making DSGN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 0 | 0 | 0 | 0 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 4 | 4 | 4 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 3.0 | 3.0 | 3.0 | 3.0 |
For the DSGN stock predictions from the analysts covering Design Therapeutics Inc, we have collected all of the individual DSGN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering DSGN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DSGN stock predictions may vary widely, another useful metric to consider is the median DSGN stock prediction, which represents the price at which half of the analysts
made DSGN stock predictions that were higher and half made DSGN stock predictions that were lower. This makes for a different take on the DSGN stock predictions out there, as compared to average or mean.
And that median across all the individual DSGN stock predictions was: $4.0 as of 2024-04-25.
The very highest of the DSGN stock predictions for one year price target was $6.0, while the very lowest of the DSGN stock predictions in the analyst group was
$4.0 (with a standard deviation of $1.154). Get the latest Zacks research report on DSGN — FREE
Find out: DSGN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CYH Stock Predictions
VUZI Stock Predictions
AIM Stock Predictions
WKHS Stock Predictions
AOUT Stock Predictions
CNO Stock Predictions
ALRM Stock Predictions
HBB Stock Predictions
FSM Stock Predictions
|
|
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |